The world is moving towards a greener economy — meaning that investors, financial institutions and the general public all want to see evidence of ESG activities associated with the money they make available to organizations.
TORONTO (PRWEB)
April 05, 2023
Every company uses energy and resources; every company affects, and is affected by, the environment. Every company operates within a broader, diverse society. Every company requires governance to function, operate and exist. Environmental, social and governance (ESG) imperatives impact every aspect of clinical trial operations. ESG is a collective term that measures a business’s impact on the environment, society at large and how robust and transparent its governance is in terms of company leadership, executive pay, audits, internal controls and shareholder rights.
The world is moving towards a greener economy — meaning that investors, financial institutions and the general public all want to see evidence of ESG activities associated with the money they make available to organizations.
A business’s reputation is increasingly defined not just by how effective its products are, its customer service, but also by how invested it is around ESG. This has knock-on secondary effects such as being a deciding factor for customers and talent.
These efforts are now a decision-making factor for companies on who they want to work with. Companies with strong ESG credentials and ambitions want to and indeed must work with other companies on a similar path if they are to achieve their targets. While currently voluntary, ESG will likely soon become a regulatory requirement. Investing in ESG activities now is crucial in preparing for the future and reducing the exposure to risk. It makes good business sense to reduce waste, which in turn lowers costs and reduces the bottom line.
Join this webinar to learn how ESG will have a profound impact on how clinical operations work is performed. By understanding an organization’s position and needs, Clinical Operations Leaders have an opportunity to take an industry leading position in ESG.
Join experts from Syneos Health, James Man, Managing Director, Syneos Health Consulting; James Taylor, Vice President, Global Client Solutions Executive, Syneos Health Global Client Solutions; and Jennifer Anderson, Associate Director, Syneos Health Environmental, Social & Governance, for the live webinar on Wednesday, April 26, 2023, at 11am EDT (4pm BST/UK).
For more information, or to register for this event, visit ESG: Creating Greener Clinical Trials.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/
Contact:
Vera Kovacevic
Tel: +1 (416) 977-6555 x371
Email: vkovacevic@xtalks.com
Share article on social media or email: